reports
ONWARD® Medical Announces Third Implant of Brain-Computer Interface (B...
ONWARD® Medical Announces Third Implant of Brain-Computer Interface (BCI) System to Restore Movement after Spinal Cord Injury Company continues pioneering research on BCI-enabled system to restore mobility after spinal cord injury EINDHOVEN, The Netherlands, Sept. 19, 2024 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative spinal cord stimulation therapies to restore movement, function, and independence in people with spinal cord injury (SCI), announces another successful implant of its investigational ARC-BCI™ System to restore ...
ONWARD® Medical annonce le troisième implant de son système d'interfac...
ONWARD® Medical annonce le troisième implant de son système d'interface cerveau-machine (BCI) pour restaurer le mouvement après une lésion de la moelle épinière La société poursuit ses recherches novatrices sur un système activé par une interface cerveau-machine (BCI) pour restaurer la mobilité après une lésion de la moelle épinière EINDHOVEN, Pays-Bas, 19 sept. 2024 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext : ONWD), société de technologie médicale à l’origine de thérapies* innovantes pour restaurer le mouvement, la fonction et l’indépendance chez les personnes atteintes de lési...
- Maxime Stranart
- Stijn Demeester
Recticel/Volumes growth back on the agenda/BUY
We reiterate our BUY and increase our target price from €15 to €16 following Recticel's 1H24 results, to reflect a lower WACC and broadly stable estimates. We remain convinced by the medium-to-long term potential of the Insulation market - this should provide Recticel with ample room to grow organically and, thanks to its net cash position, through M&A. We view future acquisitions as a key catalyst for the share price over the short term, as these would confirm the ambition of the group to mater...
- Sharad Kumar S.P
TINC 1H FY24: Stable portfolio growth; Dividend up 3.6%
NAV rose by 3% €482.0m or €13.26ps (vs. €468.0m during FY23-end). Portfolio result came in at €21.9m (9.4% annualised) while net result clocked in at €18.0m or €0.5 per share. Shareholder's equity declined slightly to €482.0m compared to €494.6m during FY23-end – this is after deducting the dividend of €30.5m (€0.84ps) paid in May'24. Total cash receipts generated by the portfolio during 1H amounted to €23.1m while TINC committed €50.2m towards 3 new projects. Currently, TINC has a net debt pos...
- Guy Sips
- Michiel Declercq
- Sharad Kumar S.P
- Sharad Kumar S.P
Holdings Report - August 2024 KBCS Holdings Universe Up 0.5% Thanks To...
1M Performance - Absolute: During July'24 (1M period), the KBCS Holdings Universe posted a return of 0.5% which was mainly driven by multi-asset holdings (+1.7%) while single-asset holdings posted a negative return of -1.3%. The 3 top performers during the period were HAL Trust (+5.1%), Texaf (+2.9%), and The Infrastructure Company (TINC, +9.6%) while the 3 worst performers were Brederode (-2.8%), Solvac (-5.3%), and Whitestone Group (-7.2%). YTD Performance - Relative: On a YTD basis (as of A...
GBLB GROUPE BRUXELLES LAMBERT SA
HAL HAL TRUST
DIE D'IETEREN SA
SOF SOFINA SA
SOLV SOLVAC S.A.
GIMB GIMV NV
QFG QUEST FOR GROWTH
ACKB ACKERMANS & VAN HAAREN NV
TUB FINANCIERE DE TUBIZE S.A.
HEIO HEINEKEN HOLDING N.V.
KBCA KBC ANCORA SCA
TEXF TEXAF
BREB BREDERODE S.A.
TINC TINC COMM. VA
ROCK WHITESTONE GROUP
- Jacob Mekhael
- Thomas Vranken
Onward Medical 1H24 update holds no surprises, ARC-EX FDA approval in ...
Onward reported its 1H24 business update, which holds no surprises, and we note that the company reiterated the timeline for the key milestone of obtaining FDA clearance to launch its ARC-EX System in the US in 4Q24. Onward's cash runway is until spring 2025, and access to tranches from its € 52.5m debt agreement could unlock funding beyond this timeline, and allow the company to show early commercial traction for ARC-EX. All in all, a positive update, and as such, we maintain our € 9.3 TP and B...
- Jacob Mekhael
- Michiel Declercq
- Wim Lewi
- Wim Lewi
Shurgard Big add-on acquisition in Germany
Shurgard announced the acquisition of Prime Self-Storage in Germany for EUR 100.0m (asset deal) that will add 24 kSqm at 7% yield. In our recent company note, we highlighted that additional M&A would continue during the Lock'nStore integration period till 2026. However, we counted on NL and FR for additions as GE already absorbed the Top Box's (Oct. 23) and the Pickens portfolio (Mar. 24). Now, SHUR reinforces its nr2 position in GE and will achieve the top spot by 2026 at the latest. Myplace...
ONWARD® Medical Reports Half Year 2024 Results and Provides a Business...
ONWARD® Medical Reports Half Year 2024 Results and Provides a Business Update THIS PRESS RELEASE CONTAINS INSIDE INFORMATION WITHIN THE MEANING OF ARTICLE 7(1) OF THE EUROPEAN MARKET ABUSE REGULATION (596/2014) Up-LIFT Study results published in Nature Medicine De Novo application submitted to FDA to obtain clearance to market the investigational ARC-EX® System in the United States Up to EUR 52.5M in growth financing obtained from US-based Runway Growth Capital Several additional milestones achieved with the investigational ARC-BCI™ System, leveraging brain-computer inte...
- Hans D’Haese
- Stijn Demeester
Gimv/Model finetune post 1Q24/25 trading update/HOLD
In a 1Q24/25 trading update that was published last week, Gimv announced a continued solid portfolio performance resulting in a positive platform portfolio return of 3.5%. This has led to an improved NAV/share of €52 at end-June, to which should be added a further €0.5/share thanks to the sale of Mega International to Bizzdesign. This positive update provides some comfort for the remainder of the year. Moreover, it seems that the lull in private equity deal activity that traditionally marks summ...
- ING Helpdesk
Benelux Morning Notes
ING Benelux Conference London: Aalberts, Arcadis, Azelis, Barco, Basic-Fit, Brunel International, DEME Group, Euronext, Fagron, Heijmans, Kinepolis, Lotus Bakeries, Melexis, Ontex, Randstad, Recticel, SBM Offshore, TKH Group, Van Lanschot Kempen Other company stories - OCI: Divestment of Methanol to Methanex for US$2.05bn, Staffing: US August temp volumes marginally better trend; NFP jobs miss
BFIT BASIC-FIT NV
SBMO SBM OFFSHORE NV
FAGR FAGRON SA
RAND RANDSTAD NV
LOTB LOTUS BAKERIES NV
REC RECTICEL SA
HEIJM HEIJMANS N.V. CERT
VLK
ARCAD VAN LANSCHOT KEMPEN NV CERT. OF SHS
AALB ARCADIS NV
OCI AALBERTS N.V.
BRNL OCI NV
ONTEX BRUNEL INTERNATIONAL N.V.
MELE ONTEX GROUP N.V.
TWEKA MELEXIS NV
KIN TKH GROUP N.V. CERT
BAR KINEPOLIS GROUP NV
AZE BARCO NV
DEME AZELIS GROUP NV
DEME GROUP NV
- ING Helpdesk
- Guy Sips
- Hilde Van Boxstael
- Kristof Samoy
- Lynn Hautekeete
- Sharad Kumar S.P
- Wim Lewi
- Guy Sips
- Jacob Mekhael
- Kristof Samoy
- Lynn Hautekeete
- Michiel Declercq
- Sharad Kumar S.P
- Thibault Leneeuw
- Thomas Couvreur
- Thomas Vranken
- Wim Hoste
- Wim Lewi
Dynamic Top Pick List Update September 2024 –Cofinimmo & Kinepolis in;...
In this September update of our Dynamic Top Pick List we make 4 changes. •We include Cofinimmo in our Dynamic Top Pick List after our recent upgrade from Accumulate to Buy. We expect the name to outperform in a decreasing interest rate environment given its relatively high leverage and cheap valuation. We also believe the risk of a dilutive equity raise eased when the FY24 capex decreased from € 320m to € 250m. The management stays disciplined in its capex program and continues to focus on asse...
BEKB BEKAERT SA
ABN ABN AMRO BANK NV DEPOSITARY RECEIPTS
FAGR FAGRON SA
EVS EVS BROADCAST EQUIPMENT SA
XIOR XIOR STUDENT HOUSING N.V.
SOLB SOLVAY SA
COFB COFINIMMO SA
DIE D'IETEREN SA
SOF SOFINA SA
VAN VAN DE VELDE S.A.
IBAB ION BEAM APPLICATIONS SA
ACKB ACKERMANS & VAN HAAREN NV
CPINV CARE PROPERTY INVEST SA
KIN KINEPOLIS GROUP NV
TINC TINC COMM. VA
FUR FUGRO NV
SYENS SYENSQO
- Sharad Kumar S.P
Gimv 1Q FY25 trading update: Wider discount opens up buying opportunit...
Gimv's 1Q trading update highlighted that portfolio return came in at 3.5%, which led to a growth in the NAVps which currently is €52.0ps, net of the €2.6ps dividend (July'24). During 1Q, Gimv's portfolio companies grew both revenues and margins and are well positioned to achieve double-digit growth during 2024. EBITDA growth has been the main driver of value creation which will also have a positive impact on NAV. Gimv has signed an agreement to sell its participation in 1 portfolio company whic...
- ING Helpdesk
- Jacob Mekhael
- Sharad Kumar S.P
- Wim Hoste
- Wim Lewi
- Jacob Mekhael
- Thomas Vranken
Onward Medical $1m grant to study brain-computer interface platform
Onward announced a $ 1.1m grant from the Christopher & Dana Reeve Foundation to support expansion of an ongoing early clinical feasibility study to explore the use of a brain-computer interface (BCI) to restore thought-driven use of the hands and arms after SCI. This technology has the potential to revolutionise the treatment of SCI, and the grant will enable Onward's research partner to generate data in additional patients, which could provide validation for Onward's approach in this emerging a...
- Wim Hoste
Recticel Model update – Structural growth drivers but no ST support fr...
We have finetuned our earnings model post the 1H24 results release, with adjusted EBITDA forecasts for FY24-26 lowered by between 2% and 5%, reflecting the competitive landscape (mainly in the Boards business). Despite the reduced forecasts, we still expect Recticel to grow adjusted EBITDA by c. 31% in FY24 and by 19% in FY25, benefiting from savings initiatives and the Rex integration & growth. Building markets are bottoming out, but we do not expect meaningful improvement in momentum until 202...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.